Genentech presents new data on MS treatment
New data on OCREVUS presented at American Academy of Neurology (AAN) annual meeting in Boston. Read More »
New data on OCREVUS presented at American Academy of Neurology (AAN) annual meeting in Boston. Read More »
AbbVie has announced the successful results of an EXPEDITION-1 Phase III study that evaluated 12 weeks of treatment with glecaprevir/pibrentasvir (G/P). Read More »
Togo became the first country in Africa recognized by the World Health Organization for eliminating lymphatic filariasis, also known as elephantiasis, as a public health problem. Read More »
A collaboration to develop biomarker technology was announced by Bristol-Myers Squibb Co. and Nordic Bioscience last week. Read More »
The Pharmaceutical Care Management Association (PCMA) has recommended that the next Food and Drug Administration (FDA) director adopt five specific strategies to encourage pharmaceutical pricing competition based on results of its recently commissioned report. Read More »
Shire PLC's Natpar, an adjunctive treatment for adult patients with chronic hypoparathyroidism, was reviewed positively by the Committee for Medicinal Products for Human Use of the European Medicines Agency. Read More »
GlaxoSmithKline (GSK) and Innoviva Inc. recently released positive results for a study evaluating Relvar Ellipta in treating asthma. Read More »
Albertson’s Cos. have trained close to 3,000 pharmacists in administering naloxone to treat patients overdosing on opioids. Read More »
Genentech's Phase II Mmotion150 study for Tecentriq compared Tecentriq plus Avastin and Tecentriq monotherapy to sunitinib alone reinforced the potential of the combination drug for the treatment of patients with previously untreated, locally advanced or metastatic renal cell carcinoma. Read More »
The Global Initiative for Asthma’s report, Global Strategy for Asthma Management and Prevention, is recommending allergy immunotherapy as a treatment option. Read More »
ArQule Inc. and Daiichi Sankyo's METIV-HCC Phase 3 study of tivantinib in hepatocellular carcinoma failed to meet its primary endpoint of improving overall survival. Read More »
Allergan will sponsor the Alzheimer's Foundation of America's (AFA) "15th Anniversary National Educating America Tour” that honors AFA’s 15 years of Alzheimer’s education. Read More »
Allergan recently announced a new campaign to raise awareness for Chronic Dry Eye, using the slogan “before we had our voice, we had eyes.” Read More »
CVS Health recently opened a MinuteClinic walk-in medical clinic inside the CVS Pharmacy store on K Street NW in Washington D.C. Read More »
Shire PLC has published results from its Phase 1b lanadelumab study in the New England Journal of Medicine. Read More »
Purdue Pharma LP's Carrie Chomiak will be stepping up into a substantial business role as lead of over-the-counter product franchise for brands including Betadine microbicide antiseptics, Slow-Mag magnesium chloride supplements, Senokot laxative and Colace stool softener. Read More »
Biologics Inc., a McKesson Specialty Health oncology pharmacy services company, has been chosen by Tesaro Inc. to provide its new drug. Read More »
The Pharmaceutical Care Management Association is beginning the DrugBenefitSolutions national campaign, in which it seeks to explain how pharmacy benefits managers are helping to reduce the price of medications and assist consumers, as well as employers and unions. Read More »
The Corporate Whistleblower Center is encouraging individuals to reach out to authorities if they know of unsanitary pharmacy practices. Read More »
Josie Martin has been named vice president of corporate affairs and communications for Purdue Pharma LP. Read More »